N-acetyltransferase 2 Polymorphisms and Risk of Esophageal Cancer in a Chinese Population
Overview
Authors
Affiliations
Esophageal cancer was the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related death in China in 2009. Genetic factors might play an important role in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). We conducted a hospital-based case-control study to evaluate ten NAT2 tagging single nucleotide polymorphisms (SNPs) on the risk of ESCC. Six hundred and twenty-nine ESCC cases and 686 controls were recruited. Their genotypes were determined using the ligation detection reaction method. In the single locus analyses, there was a borderline statistically significant difference in genotype frequencies of NAT2 rs1565684 T>C SNP between the cases and the controls (p = 0.057). The NAT2 rs1565684 CC genotype was associated with a borderline significantly increased risk for ESCC (CC vs. TT: adjusted OR = 1.77, 95% CI = 0.97-3.21, p = 0.063 and CC vs. TT/TC: adjusted OR = 1.68, 95% CI = 0.93-3.04, p = 0.085). The association was evident among older patients and patients who never drunk. After the Bonferroni correction, in all comparison models, NAT2 rs1565684 T>C SNP was not associated with ESCC risk (p>0.05). For the other nine NAT2 SNPs, after Bonferroni correction, in all comparison models, the nine SNPs were also not associated with ESCC risk (p>0.05). Thus, nine NAT2 tagging SNPs were not associated with risk of ESCC. NAT2 rs1565684 T>C SNP might play a slight role in ESCC etiology. Additional, larger studies and tissue-specific biological characterization are required to confirm the current findings.
Tang W, Wang J, Dai T, Qiu H, Liu C, Chen S Cancer Med. 2024; 13(8):e7178.
PMID: 38659416 PMC: 11043686. DOI: 10.1002/cam4.7178.
Esophageal cancer genetics in South Africa.
Alaouna M, Hull R, Penny C, Dlamini Z Clin Exp Gastroenterol. 2019; 12:157-177.
PMID: 31114287 PMC: 6485038. DOI: 10.2147/CEG.S182000.
Gene Polymorphisms in Turkish Patients with Psoriasis Vulgaris.
Dursun R, Dursun H, Zamani A, Yildirim M, Cinar I Biomed Res Int. 2018; 2018:3258708.
PMID: 29992137 PMC: 6016222. DOI: 10.1155/2018/3258708.
Wang L, Gu H, Long T, Pan H, Lv L, Shi Y Oncotarget. 2017; 8(55):93655-93671.
PMID: 29212180 PMC: 5706826. DOI: 10.18632/oncotarget.20675.
Jia Y, Hu X, Gabriella H, Qin L, Meggyeshazi N Evid Based Complement Alternat Med. 2015; 2015:464937.
PMID: 26495015 PMC: 4606195. DOI: 10.1155/2015/464937.